Compare Cigna Corporation (CI) vs UnitedHealth Group Incorporated (UNH) vs CVS Health Corporation (CVS) Stock

UnitedHealth Group Incorporated (UNH) offers the better valuation at 18.8x trailing P/E (16.4x forward), making it the more compelling value choice. Analysts rate Cigna Corporation (CI) a "Buy" — based on 39 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, UnitedHealth Group Incorporated (UNH) is the cheapest at 18.8x versus CVS Health Corporation at 57.5x. On forward P/E, Cigna Corporation is actually cheaper at 9.6x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, Cigna Corporation (CI) delivered a total return of +46.5%, compared to -1.5% for UnitedHealth Group Incorporated (UNH). A $10,000 investment in CI five years ago would be worth approximately $15K today (assuming dividends reinvested). Over 10 years, the gap is even starker: UNH returned +191.5% versus CVS's +4.7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Cigna Corporation (CI) is the lower-risk stock at 0.19β versus UnitedHealth Group Incorporated's 0.28β — meaning UNH is approximately 50% more volatile than CI relative to the S&P 500. On balance sheet safety, UnitedHealth Group Incorporated (UNH) carries a lower debt/equity ratio of 77% versus 124% for CVS Health Corporation — giving it more financial flexibility in a downturn.

UnitedHealth Group Incorporated (UNH) is the more profitable company, earning 3.2% net margin versus 0.4% for CVS Health Corporation — meaning it keeps 3.2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: UNH leads at 4.2% versus 2.6% for CVS. At the gross margin level — before operating expenses — UNH leads at 18.5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Cigna Corporation (CI) trades at 9.6x forward P/E versus 16.4x for UnitedHealth Group Incorporated — 6.9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for UNH: 31.4% to $385.38.

All stocks in this comparison pay dividends. UnitedHealth Group Incorporated (UNH) offers the highest yield at 5.2%, versus 1.9% for Cigna Corporation (CI).

For long-horizon retirement investors, Cigna Corporation (CI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.19), 1.9% yield, +125.7% 10Y return). Both have compounded well over 10 years (CI: +125.7%, CVS: +4.7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both. In terms of investment character: CI is a mid-cap quality compounder stock; UNH is a large-cap income-oriented stock; CVS is a mid-cap income-oriented stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.